Cargando…
731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108149/ http://dx.doi.org/10.1016/S0016-5085(21)01104-5 |
| _version_ | 1783690075947663360 |
|---|---|
| author | Dailey, Joelynn Hyams, Jeffrey S. Hopkins, Dena Grandonico, Kristen Brimacombe, Michael Lapin, Blaine Schreiber, John Kozhaya, Lina Dogan, Mikail Placek, Lindsey Renzullo, Stephanie Gunter, Courtney L. Salazar, Juan C. Unutmaz, Derya |
| author_facet | Dailey, Joelynn Hyams, Jeffrey S. Hopkins, Dena Grandonico, Kristen Brimacombe, Michael Lapin, Blaine Schreiber, John Kozhaya, Lina Dogan, Mikail Placek, Lindsey Renzullo, Stephanie Gunter, Courtney L. Salazar, Juan C. Unutmaz, Derya |
| author_sort | Dailey, Joelynn |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8108149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81081492021-05-10 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS Dailey, Joelynn Hyams, Jeffrey S. Hopkins, Dena Grandonico, Kristen Brimacombe, Michael Lapin, Blaine Schreiber, John Kozhaya, Lina Dogan, Mikail Placek, Lindsey Renzullo, Stephanie Gunter, Courtney L. Salazar, Juan C. Unutmaz, Derya Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2021-05 2021-05-10 /pmc/articles/PMC8108149/ http://dx.doi.org/10.1016/S0016-5085(21)01104-5 Text en Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Dailey, Joelynn Hyams, Jeffrey S. Hopkins, Dena Grandonico, Kristen Brimacombe, Michael Lapin, Blaine Schreiber, John Kozhaya, Lina Dogan, Mikail Placek, Lindsey Renzullo, Stephanie Gunter, Courtney L. Salazar, Juan C. Unutmaz, Derya 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS |
| title | 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS |
| title_full | 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS |
| title_fullStr | 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS |
| title_full_unstemmed | 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS |
| title_short | 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS |
| title_sort | 731 failure to develop neutralizing antibodies following sars-cov-2 infection in young patients with inflammatory bowel disease receiving biologics |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108149/ http://dx.doi.org/10.1016/S0016-5085(21)01104-5 |
| work_keys_str_mv | AT daileyjoelynn 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT hyamsjeffreys 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT hopkinsdena 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT grandonicokristen 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT brimacombemichael 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT lapinblaine 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT schreiberjohn 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT kozhayalina 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT doganmikail 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT placeklindsey 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT renzullostephanie 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT guntercourtneyl 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT salazarjuanc 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics AT unutmazderya 731failuretodevelopneutralizingantibodiesfollowingsarscov2infectioninyoungpatientswithinflammatoryboweldiseasereceivingbiologics |